Home / United States / Sixarp, LLC
Drug factory · FDA FEI 1000115322
Sixarp, LLC
7650 Caterpillar CT SW D, Grand Rapids, MI, United States
United States: 1
No problems found at FDA's last inspection, Mar 6, 2025.
No Action Indicated: inspectors found no objectionable conditions.
4 drug inspections on record since 2010: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
Drug Role For NDC
Albuterol Makes it, packages it and labels it
Praxis, LLC 59368-401 , 59368-412 Butorphanol Makes it, packages it and labels it
Praxis, LLC 59368-400 Dabigatran Packages it and labels it
Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0108 , 0597-0355 , 0597-0360 +6Empagliflozin and Linagliptin Packages it and labels it
Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0164 , 0597-0182 Estradiol Makes it, packages it and labels it
Bayer HealthCare Pharmaceuticals Inc. , Praxis, LLC 50419-451 , 50419-452 , 50419-453 +9Estradiol and Levonorgestrel Packages it
Bayer HealthCare Pharmaceuticals Inc. 50419-491 Hydrochlorothiazide and Telmisartan Packages it and labels it
Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0042 , 0597-0043 , 0597-0044 Ibuprofen Makes it, packages it and labels it
Praxis, LLC 59368-402 Linagliptin Packages it and labels it
Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0140 Linagliptin and Metformin Packages it and labels it
Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0146 , 0597-0147 , 0597-0148 Lisinopril Makes it, packages it and labels it
Praxis, LLC 59368-406 Mycophenolic Acid Makes it, packages it and labels it
Praxis, LLC 59368-403 Tamsulosin Packages it and labels it
Sanofi-Aventis U.S. LLC 0024-5837 Topiramate Makes it, packages it and labels it
Praxis, LLC 59368-405 Triptorelin Makes it, packages it and labels it
Praxis, LLC 59368-404 Zonisamide Makes it, packages it and labels it
Praxis, LLC 59368-407
FDA inspection history
Ended Result Program Problems noted
Mar 6, 2025 No problems found Drug Quality Assurance — Feb 5, 2019 No problems found Drug Quality Assurance — Apr 25, 2014 No problems found Drug Quality Assurance — May 28, 2010 Problems found, fixed voluntarily Drug Quality Assurance 2
What inspectors wrote down
From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.
May 28, 2010 inspection
Investigations made into any unexplained discrepancy 21 CFR 211.188(b)(12) Procedures not in writing, fully followed 21 CFR 211.22(d) Registered with FDA for: label; manufacture; pack; relabel; repack.
